img

Global Liposomal Amphoteracin B Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Liposomal Amphoteracin B Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Ambisome (amphotericin B) is used to treat serious, life-threatening fungal infections, including a certain form of meningitis. 
Liposomal Amphoteracin B report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Liposomal Amphoteracin B market is projected to reach US$ 740.5 million in 2029, increasing from US$ 496 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Liposomal Amphoteracin B industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Liposomal Amphoteracin B key manufacturers include Gilead Sciences and Cipla etc. Gilead Sciences, Cipla, are top 3 players and held % sales share in total in 2022.
Liposomal Amphoteracin B can be divided into 25mg and 50mg, etc. 25mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Liposomal Amphoteracin B is widely used in various fields, such as Hospital and Pharmacy, etc. Hospital provides greatest supports to the Liposomal Amphoteracin B industry development. In 2022, global % sales of Liposomal Amphoteracin B went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Liposomal Amphoteracin B market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Gilead Sciences
Cipla
Segment by Type
25mg
50mg

Segment by Application


Hospital
Pharmacy

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Liposomal Amphoteracin B market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Liposomal Amphoteracin B, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Liposomal Amphoteracin B industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Liposomal Amphoteracin B in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Liposomal Amphoteracin B introduction, etc. Liposomal Amphoteracin B Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Liposomal Amphoteracin B market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Liposomal Amphoteracin B Market Overview
1.1 Liposomal Amphoteracin B Product Overview
1.2 Liposomal Amphoteracin B Market Segment by Type
1.2.1 25mg
1.2.2 50mg
1.3 Global Liposomal Amphoteracin B Market Size by Type
1.3.1 Global Liposomal Amphoteracin B Market Size Overview by Type (2018-2029)
1.3.2 Global Liposomal Amphoteracin B Historic Market Size Review by Type (2018-2024)
1.3.3 Global Liposomal Amphoteracin B Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Liposomal Amphoteracin B Sales Breakdown by Type (2018-2024)
1.4.2 Europe Liposomal Amphoteracin B Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Liposomal Amphoteracin B Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Liposomal Amphoteracin B Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Liposomal Amphoteracin B Sales Breakdown by Type (2018-2024)
2 Global Liposomal Amphoteracin B Market Competition by Company
2.1 Global Top Players by Liposomal Amphoteracin B Sales (2018-2024)
2.2 Global Top Players by Liposomal Amphoteracin B Revenue (2018-2024)
2.3 Global Top Players by Liposomal Amphoteracin B Price (2018-2024)
2.4 Global Top Manufacturers Liposomal Amphoteracin B Manufacturing Base Distribution, Sales Area, Product Type
2.5 Liposomal Amphoteracin B Market Competitive Situation and Trends
2.5.1 Liposomal Amphoteracin B Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Liposomal Amphoteracin B Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomal Amphoteracin B as of 2022)
2.7 Date of Key Manufacturers Enter into Liposomal Amphoteracin B Market
2.8 Key Manufacturers Liposomal Amphoteracin B Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Liposomal Amphoteracin B Status and Outlook by Region
3.1 Global Liposomal Amphoteracin B Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Liposomal Amphoteracin B Historic Market Size by Region
3.2.1 Global Liposomal Amphoteracin B Sales in Volume by Region (2018-2024)
3.2.2 Global Liposomal Amphoteracin B Sales in Value by Region (2018-2024)
3.2.3 Global Liposomal Amphoteracin B Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Liposomal Amphoteracin B Forecasted Market Size by Region
3.3.1 Global Liposomal Amphoteracin B Sales in Volume by Region (2024-2029)
3.3.2 Global Liposomal Amphoteracin B Sales in Value by Region (2024-2029)
3.3.3 Global Liposomal Amphoteracin B Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Liposomal Amphoteracin B by Application
4.1 Liposomal Amphoteracin B Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Liposomal Amphoteracin B Market Size by Application
4.2.1 Global Liposomal Amphoteracin B Market Size Overview by Application (2018-2029)
4.2.2 Global Liposomal Amphoteracin B Historic Market Size Review by Application (2018-2024)
4.2.3 Global Liposomal Amphoteracin B Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Liposomal Amphoteracin B Sales Breakdown by Application (2018-2024)
4.3.2 Europe Liposomal Amphoteracin B Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Liposomal Amphoteracin B Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Liposomal Amphoteracin B Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Liposomal Amphoteracin B Sales Breakdown by Application (2018-2024)
5 North America Liposomal Amphoteracin B by Country
5.1 North America Liposomal Amphoteracin B Historic Market Size by Country
5.1.1 North America Liposomal Amphoteracin B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Liposomal Amphoteracin B Sales in Volume by Country (2018-2024)
5.1.3 North America Liposomal Amphoteracin B Sales in Value by Country (2018-2024)
5.2 North America Liposomal Amphoteracin B Forecasted Market Size by Country
5.2.1 North America Liposomal Amphoteracin B Sales in Volume by Country (2024-2029)
5.2.2 North America Liposomal Amphoteracin B Sales in Value by Country (2024-2029)
6 Europe Liposomal Amphoteracin B by Country
6.1 Europe Liposomal Amphoteracin B Historic Market Size by Country
6.1.1 Europe Liposomal Amphoteracin B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Liposomal Amphoteracin B Sales in Volume by Country (2018-2024)
6.1.3 Europe Liposomal Amphoteracin B Sales in Value by Country (2018-2024)
6.2 Europe Liposomal Amphoteracin B Forecasted Market Size by Country
6.2.1 Europe Liposomal Amphoteracin B Sales in Volume by Country (2024-2029)
6.2.2 Europe Liposomal Amphoteracin B Sales in Value by Country (2024-2029)
7 Asia-Pacific Liposomal Amphoteracin B by Region
7.1 Asia-Pacific Liposomal Amphoteracin B Historic Market Size by Region
7.1.1 Asia-Pacific Liposomal Amphoteracin B Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Liposomal Amphoteracin B Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Liposomal Amphoteracin B Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Liposomal Amphoteracin B Forecasted Market Size by Region
7.2.1 Asia-Pacific Liposomal Amphoteracin B Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Liposomal Amphoteracin B Sales in Value by Region (2024-2029)
8 Latin America Liposomal Amphoteracin B by Country
8.1 Latin America Liposomal Amphoteracin B Historic Market Size by Country
8.1.1 Latin America Liposomal Amphoteracin B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Liposomal Amphoteracin B Sales in Volume by Country (2018-2024)
8.1.3 Latin America Liposomal Amphoteracin B Sales in Value by Country (2018-2024)
8.2 Latin America Liposomal Amphoteracin B Forecasted Market Size by Country
8.2.1 Latin America Liposomal Amphoteracin B Sales in Volume by Country (2024-2029)
8.2.2 Latin America Liposomal Amphoteracin B Sales in Value by Country (2024-2029)
9 Middle East and Africa Liposomal Amphoteracin B by Country
9.1 Middle East and Africa Liposomal Amphoteracin B Historic Market Size by Country
9.1.1 Middle East and Africa Liposomal Amphoteracin B Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Liposomal Amphoteracin B Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Liposomal Amphoteracin B Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Liposomal Amphoteracin B Forecasted Market Size by Country
9.2.1 Middle East and Africa Liposomal Amphoteracin B Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Liposomal Amphoteracin B Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Gilead Sciences
10.1.1 Gilead Sciences Company Information
10.1.2 Gilead Sciences Introduction and Business Overview
10.1.3 Gilead Sciences Liposomal Amphoteracin B Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Gilead Sciences Liposomal Amphoteracin B Products Offered
10.1.5 Gilead Sciences Recent Development
10.2 Cipla
10.2.1 Cipla Company Information
10.2.2 Cipla Introduction and Business Overview
10.2.3 Cipla Liposomal Amphoteracin B Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Cipla Liposomal Amphoteracin B Products Offered
10.2.5 Cipla Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Liposomal Amphoteracin B Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Liposomal Amphoteracin B Industrial Chain Analysis
11.4 Liposomal Amphoteracin B Market Dynamics
11.4.1 Liposomal Amphoteracin B Industry Trends
11.4.2 Liposomal Amphoteracin B Market Drivers
11.4.3 Liposomal Amphoteracin B Market Challenges
11.4.4 Liposomal Amphoteracin B Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Liposomal Amphoteracin B Distributors
12.3 Liposomal Amphoteracin B Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 25mg
Table 2. Major Company of 50mg
Table 3. Global Liposomal Amphoteracin B Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Liposomal Amphoteracin B Sales by Type (2018-2024) & (K Units)
Table 5. Global Liposomal Amphoteracin B Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Liposomal Amphoteracin B Sales by Type (2018-2024) & (US& Million)
Table 7. Global Liposomal Amphoteracin B Market Share in Value by Type (2018-2024)
Table 8. Global Liposomal Amphoteracin B Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Liposomal Amphoteracin B Sales by Type (2024-2029) & (K Units)
Table 10. Global Liposomal Amphoteracin B Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Liposomal Amphoteracin B Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Liposomal Amphoteracin B Sales Market Share in Value by Type (2024-2029)
Table 13. Global Liposomal Amphoteracin B Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Liposomal Amphoteracin B Sales by Type (2018-2024) & (K Units)
Table 15. North America Liposomal Amphoteracin B Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Liposomal Amphoteracin B Sales (K Units) by Type (2018-2024)
Table 17. Europe Liposomal Amphoteracin B Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Liposomal Amphoteracin B Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Liposomal Amphoteracin B Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Liposomal Amphoteracin B Sales (K Units) by Type (2018-2024)
Table 21. Latin America Liposomal Amphoteracin B Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Liposomal Amphoteracin B Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Liposomal Amphoteracin B Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Liposomal Amphoteracin B Sales by Company (2018-2024) & (K Units)
Table 25. Global Liposomal Amphoteracin B Sales Share by Company (2018-2024)
Table 26. Global Liposomal Amphoteracin B Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Liposomal Amphoteracin B Revenue Share by Company (2018-2024)
Table 28. Global Market Liposomal Amphoteracin B Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Liposomal Amphoteracin B Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Liposomal Amphoteracin B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomal Amphoteracin B as of 2022)
Table 32. Date of Key Manufacturers Enter into Liposomal Amphoteracin B Market
Table 33. Key Manufacturers Liposomal Amphoteracin B Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Liposomal Amphoteracin B Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Liposomal Amphoteracin B Sales by Region (2018-2024) & (K Units)
Table 37. Global Liposomal Amphoteracin B Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Liposomal Amphoteracin B Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Liposomal Amphoteracin B Sales Market Share in Value by Region (2018-2024)
Table 40. Global Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Liposomal Amphoteracin B Sales by Region (2024-2029) & (K Units)
Table 42. Global Liposomal Amphoteracin B Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Liposomal Amphoteracin B Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Liposomal Amphoteracin B Sales Market Share in Value by Region (2024-2029)
Table 45. Global Liposomal Amphoteracin B Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Liposomal Amphoteracin B Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Liposomal Amphoteracin B Sales by Application (2018-2024) & (K Units)
Table 48. Global Liposomal Amphoteracin B Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Liposomal Amphoteracin B Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Liposomal Amphoteracin B Sales Market Share in Value by Application (2018-2024)
Table 51. Global Liposomal Amphoteracin B Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Liposomal Amphoteracin B Sales by Application (2024-2029) & (K Units)
Table 53. Global Liposomal Amphoteracin B Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Liposomal Amphoteracin B Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Liposomal Amphoteracin B Sales Market Share in Value by Application (2024-2029)
Table 56. Global Liposomal Amphoteracin B Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Liposomal Amphoteracin B Sales by Application (2018-2024) (K Units)
Table 58. North America Liposomal Amphoteracin B Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Liposomal Amphoteracin B Sales by Application (2018-2024) (K Units)
Table 60. Europe Liposomal Amphoteracin B Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Liposomal Amphoteracin B Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Liposomal Amphoteracin B Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Liposomal Amphoteracin B Sales by Application (2018-2024) (K Units)
Table 64. Latin America Liposomal Amphoteracin B Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Liposomal Amphoteracin B Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Liposomal Amphoteracin B Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Liposomal Amphoteracin B Sales by Country (2018-2024) & (K Units)
Table 68. North America Liposomal Amphoteracin B Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Liposomal Amphoteracin B Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Liposomal Amphoteracin B Sales Market Share in Value by Country (2018-2024)
Table 71. North America Liposomal Amphoteracin B Sales by Country (2024-2029) & (K Units)
Table 72. North America Liposomal Amphoteracin B Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Liposomal Amphoteracin B Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Liposomal Amphoteracin B Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Liposomal Amphoteracin B Sales by Country (2018-2024) & (K Units)
Table 76. Europe Liposomal Amphoteracin B Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Liposomal Amphoteracin B Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Liposomal Amphoteracin B Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Liposomal Amphoteracin B Sales by Country (2024-2029) & (K Units)
Table 80. Europe Liposomal Amphoteracin B Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Liposomal Amphoteracin B Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Liposomal Amphoteracin B Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Liposomal Amphoteracin B Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Liposomal Amphoteracin B Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Liposomal Amphoteracin B Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Liposomal Amphoteracin B Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Liposomal Amphoteracin B Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Liposomal Amphoteracin B Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Liposomal Amphoteracin B Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Liposomal Amphoteracin B Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Liposomal Amphoteracin B Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Liposomal Amphoteracin B Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Liposomal Amphoteracin B Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Liposomal Amphoteracin B Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Liposomal Amphoteracin B Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Liposomal Amphoteracin B Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Liposomal Amphoteracin B Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Liposomal Amphoteracin B Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Liposomal Amphoteracin B Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Liposomal Amphoteracin B Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Liposomal Amphoteracin B Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Liposomal Amphoteracin B Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Liposomal Amphoteracin B Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Liposomal Amphoteracin B Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Liposomal Amphoteracin B Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Liposomal Amphoteracin B Sales Market Share in Value by Country (2024-2029)
Table 107. Gilead Sciences Company Information
Table 108. Gilead Sciences Introduction and Business Overview
Table 109. Gilead Sciences Liposomal Amphoteracin B Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Gilead Sciences Liposomal Amphoteracin B Product
Table 111. Gilead Sciences Recent Development
Table 112. Cipla Company Information
Table 113. Cipla Introduction and Business Overview
Table 114. Cipla Liposomal Amphoteracin B Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Cipla Liposomal Amphoteracin B Product
Table 116. Cipla Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Liposomal Amphoteracin B Market Trends
Table 120. Liposomal Amphoteracin B Market Drivers
Table 121. Liposomal Amphoteracin B Market Challenges
Table 122. Liposomal Amphoteracin B Market Restraints
Table 123. Liposomal Amphoteracin B Distributors List
Table 124. Liposomal Amphoteracin B Downstream Customers
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomal Amphoteracin B Product Picture
Figure 2. Global Liposomal Amphoteracin B Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Liposomal Amphoteracin B Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Liposomal Amphoteracin B Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 25mg
Figure 6. Global 25mg Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 50mg
Figure 8. Global 50mg Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Liposomal Amphoteracin B Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Liposomal Amphoteracin B Sales Market Share by Type in 2022 & 2029
Figure 11. North America Liposomal Amphoteracin B Sales Market Share in Volume by Type in 2022
Figure 12. North America Liposomal Amphoteracin B Sales Market Share in Value by Type in 2022
Figure 13. Europe Liposomal Amphoteracin B Sales Market Share in Volume by Type in 2022
Figure 14. Europe Liposomal Amphoteracin B Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Liposomal Amphoteracin B Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Liposomal Amphoteracin B Sales Market Share in Value by Type in 2022
Figure 17. Latin America Liposomal Amphoteracin B Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Liposomal Amphoteracin B Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Liposomal Amphoteracin B Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Liposomal Amphoteracin B Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Liposomal Amphoteracin B Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Liposomal Amphoteracin B Revenue in 2022
Figure 23. Liposomal Amphoteracin B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Pharmacy
Figure 27. Global Pharmacy Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Liposomal Amphoteracin B Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Liposomal Amphoteracin B Sales Market Share by Application in 2022 & 2029
Figure 30. North America Liposomal Amphoteracin B Sales Market Share in Volume by Application in 2022
Figure 31. North America Liposomal Amphoteracin B Sales Market Share in Value by Application in 2022
Figure 32. Europe Liposomal Amphoteracin B Sales Market Share in Volume by Application in 2022
Figure 33. Europe Liposomal Amphoteracin B Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Liposomal Amphoteracin B Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Liposomal Amphoteracin B Sales Market Share in Value by Application in 2022
Figure 36. Latin America Liposomal Amphoteracin B Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Liposomal Amphoteracin B Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Liposomal Amphoteracin B Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Liposomal Amphoteracin B Manufacturing Cost Structure
Figure 41. Liposomal Amphoteracin B Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries